Aclaris Therapeutics (ACRS) Other Non-Current Assets (2014 - 2026)
Aclaris Therapeutics (ACRS) recorded Other Assets of $2.2 million in Q2 2026, down 26.5% from $2.99 million a year earlier and down 7.1% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Other Non-Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Aclaris Therapeutics reported Other Assets of $2.77 million, down 9.6% from FY2024.
- Annual Other Assets has a five-year compound annual growth rate of -9.3% (FY2020 to FY2025).
- Across earlier years, Other Assets came in at $3.07 million in FY2024 (-26.3%), $4.16 million in FY2023 (+52.2%), $2.73 million in FY2022 (-23.1%) and $3.55 million in FY2021 (-21.3%).
- The Q2 2026 figure is the lowest quarterly Other Assets since Q3 2018.
- On a year-over-year basis, Other Assets has declined for seven consecutive quarters, with an average decline of 13.8% over the last eight quarters.
- Peak year-over-year performance for Other Assets in the last five years was growth of 52.2% in Q4 2023, against a decline of 43.3% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.37 million (Q1 2026), $2.77 million (Q4 2025) and $2.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Aclaris Therapeutics | 638.89 Mn | 236.88 Mn | 1.29 Mn | 1.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.99 Mn |
| Jun 30, 2026 | 2.20 Mn |
| Mar 31, 2026 | 2.37 Mn |
| Dec 31, 2025 | 2.77 Mn |
| Sep 30, 2025 | 2.83 Mn |
| Jun 30, 2025 | 2.99 Mn |
| Mar 31, 2025 | 3.15 Mn |
| Dec 31, 2024 | 3.07 Mn |
| Sep 30, 2024 | 3.22 Mn |
| Jun 30, 2024 | 3.37 Mn |
| Mar 31, 2024 | 4.00 Mn |
| Dec 31, 2023 | 4.16 Mn |
| Sep 30, 2023 | 2.66 Mn |
| Jun 30, 2023 | 2.89 Mn |
| Mar 31, 2023 | 3.28 Mn |
| Dec 31, 2022 | 2.73 Mn |
| Sep 30, 2022 | 2.92 Mn |
| Jun 30, 2022 | 3.11 Mn |
| Mar 31, 2022 | 3.38 Mn |
| Dec 31, 2021 | 3.55 Mn |
API Access
Aclaris Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();